ArticleCells2022

Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.

Cristina Di Giorgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.